Dr. Shraddha Srinivasan, MD

Dr. Srinivasan practices at Columbia University Irving Medical Center in New York, New York.

Dr. Srinivasan's NPI, 1235317306, was assigned on January 31, 2008. Dr. Srinivasan graduated from Baroda Medical College in 2000. Dr. Srinivasan holds New York license 272669.

Dr. Srinivasan's primary practice is Columbia University Irving Medical Center, at 622 W 168th St, New York, NY 10032 in New York County. The practice phone is (212) 297-4255.

Dr. Srinivasan's primary practice is Columbia University Irving Medical Center in New York, New York. Dr. Srinivasan is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is ColumbiaDoctors. Dmand AI also links Dr. Srinivasan to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Srinivasan practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Srinivasan's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Srinivasan is board certified in epilepsy by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Srinivasan's licenses on file in 4 states: New York, Florida, New Jersey and Massachusetts.

Dmand AI lists epilepsy and seizures among the conditions Dr. Srinivasan treats.

CMS data shows 532 Medicare services from Dr. Srinivasan across 9 procedure codes in 2024, for 212 Medicare patients. Medicare paid $67,955 for them.

CMS counts 212 Medicare patients who saw Dr. Srinivasan in 2024. The largest group is 75 to 84, with 64 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 56% are also on Medicaid. Their average risk score is 2.48, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Srinivasan's median patient age at 44, with 52% women.

In 2024, Dr. Srinivasan wrote 1,683 Medicare Part D claims for 193 patients. 80% of them were for generic drugs. CMS names the drug for 1,501 of them, across 28 drugs with 11 or more claims each, at $484,445 in total drug cost. In 2023, CMS named 1,234 claims across 27 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Srinivasan for performance year 2024, reported through an alternative payment model (APM). Dr. Srinivasan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Srinivasan as offering telehealth.

Dmand AI links 22 papers to Dr. Srinivasan, published from 2011 to 2021. 2012 was the busiest year, with 3. The most frequent topics are Seizures, Electroencephalography and Epilepsy. Dr. Srinivasan has published most often in Epilepsia. Dr. Srinivasan's most frequent co-authors are Carl W. Bazil, MD, PhD, Hyunmi Choi, MD and Alison M. Pack, MD.

CMS Open Payments shows 19 general payments to Dr. Srinivasan from 2 drug and device companies from 2017 to 2024. Education make up the largest share, 60% of the total. Neuropace, Inc. paid the most, $3,553. It also lists 11 research payments totaling $33,044 from 2016 to 2018.

Dr. Srinivasan graduated from Baroda Medical College in 2000.

Dr. Srinivasan is in network with 14 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.